Key result
Older patient age significantly increased the risk of 30-day mortality following transvenous lead extraction (4.9% in octogenarians vs 0.4% in young patients; OR 1.064, 95% CI 1.013-1.116).
Why the study?
Patient age is a recognized risk factor for unfavorable outcomes in invasive procedures, prompting evaluation of the association between age and non-laser transvenous lead extraction outcomes.
Does patient age influence procedural outcomes, complications, and 30-day mortality in patients undergoing non-laser transvenous lead extraction?
Cohort (n=2,052)
Yes
Does patient age influence procedural outcomes, complications, and 30-day mortality in patients undergoing non-laser transvenous lead extraction?
Odds Ratio: 1.064 (95% CI 1.013–1.116)
Absolute Event Rate: 4.9% vs 0.4%
p-value: p=0.013
Non-laser transvenous lead extraction is procedurally safe and effective across all age groups, though advancing age and systemic infection independently increase the risk of 30-day mortality.
No takes yet. Share an insight, caveat, or question.
Non-laser TLE is safe and effective across ages; extends evidence that procedural success is age-independent while leaving mortality risk open for prospective study.
Akhtar et al. (2021) conducted a cohort in Cardiac implantable electronic device requiring transvenous lead extraction (n=2,052). Older age vs. Younger age was evaluated on 30-day mortality (OR 1.064, 95% CI 1.013-1.116, p=0.013). Older patient age significantly increased the risk of 30-day mortality following transvenous lead extraction (4.9% in octogenarians vs 0.4% in young patients; OR 1.064, 95% CI 1.013-1.116).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: